PharmaResources (Shanghai) Co. Ltd. A (301230) — Cash Flow Quality Index
PharmaResources (Shanghai) Co. Ltd. A (301230) has a Cash Flow Quality Index of 3.95x as of December 2025. Operating cash flow of CN¥135.51 Million exceeds net income of CN¥34.29 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of PharmaResources (Shanghai) Co. Ltd. A to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmaResources (Shanghai) Co. Ltd. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of PharmaResources (Shanghai) Co. Ltd. A to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Year-by-year earnings quality comparison for PharmaResources (Shanghai) Co. Ltd. A. For live market cap and the full company financial profile, see 301230 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.95x | CN¥135.51 Million | CN¥34.29 Million | ▼ -16.5% |
| 2024 | 4.73x | CN¥80.86 Million | CN¥17.08 Million | ▲ +753.7% |
| 2023 | 0.55x | CN¥20.86 Million | CN¥37.62 Million | ▼ -62.5% |
| 2022 | 1.48x | CN¥99.29 Million | CN¥67.18 Million | ▲ +3.5% |
| 2021 | 1.43x | CN¥105.12 Million | CN¥73.58 Million | ▲ +27.8% |
| 2020 | 1.12x | CN¥54.45 Million | CN¥48.69 Million | — |